L. Tsurkan

发表

ATP-dependent Mitochondrial Porphyrin Importer ABCB6 Protects against Phenylhydrazine Toxicity*

J. Rehg, P. Potter, J. Schuetz, 2012, The Journal of Biological Chemistry.

Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma

R. Moats, P. Potter, R. Seeger, 2016, Molecular therapy oncolytics.

Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Sompop Bencharit, M. Redinbo, C. Morton, 2005, Journal of molecular biology.

Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.

R. K. Guy, P. Potter, M. Danks, 2007, Journal of medicinal chemistry.

Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

M. Wierdl, P. Potter, R. M. Wadkins, 2007, Bioorganic & medicinal chemistry.

Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

P. Potter, A. Lemoff, C. Jeffries, 2013, Journal of natural products.

Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.

P. Potter, Carol C Edwards, Philip M Potter, 2013, Chemico-biological interactions.

Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

Elizabeth I. Parkinson, P. Potter, B. Yan, 2011, Bioorganic & medicinal chemistry.

Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin

L. Tsurkan, P. Potter, R. M. Wadkins, 2010, British journal of pharmacology.

Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds

Bruce D. Hammock, Matthew R. Redinbo, Paul D. Jones, 2007, Molecular Pharmacology.

Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.

P. Potter, T. Shaver, C. Edwards, 2011, Biochemical pharmacology.

Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

M. Wierdl, P. Potter, M. Danks, 2007, Journal of medicinal chemistry.

Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity

M. Wierdl, P. Potter, M. Danks, 2006, Molecular Cancer Therapeutics.

Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

P. Potter, R. M. Wadkins, Shana V. Stoddard, 2009, Journal of medicinal chemistry.

Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11.

J. Sussman, I. Silman, M. Harel, 2005, Chemico-biological interactions.